LSX Medtech Panelists Talk AI, Market Access Strategies, Digital Therapeutics Reimbursement
Executive Summary
Highlights from Medtech Insight's on-the-ground coverage of LSX in Boston.
Topics
- Subjects
- Digital Health
- Artificial Intelligence
- Approvals
- Behavioral Health
- Business Strategies
- Commercial
- Launches
- Legislation
- Innovation
- FDA
- Regulatory
- Reimbursement
- Research & Development
- Therapy Areas
- Cancer
- Cardiovascular
- Device Areas
- Surgical Procedures
- Neurology
- In Vitro Diagnostics
- Diabetic Care
- Industries
- Consumer
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MT155113
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
MT155113
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
Highlights from panel discussions at the LSX conference in Boston, including medtech leaders’ vision for AI integration in health care, key strategies for a successful product launch, and implications of CMS’ proposed HCPCScodes for digital therapeutics.